HBP fundamentals
An in-depth look to HELIX BIOPHARMA CORP operating, investing, and financing activities
HBP free cash flow for Q4 24 is -750 k CAD. For 2024, HBP free cash flow was -5.23 M CAD and operating cash flow was -5.22 M CAD.
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CAD
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM